Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 4. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 5. Rapid correction of low vitamin D status in nursing home residents
Top Ten Searches
etanercept hypertension chf antiphospholipid fibrosis mrsa scid renal cell rickets counterpulsationYour Article Summary
See Latest ArticlesPharmaco-active stents
Sang Thrombose Vaisseaux, 11/04/09
Juliard JM – The rational use of these stents requires choosing lesions at high–risk for restenosis (long lesions on small vessels, for example) in patients who can be monitored for at least one year and a dual antiplatelet therapy, which sudden discontinuation of which is a strong and independent risk factor for acute stent thrombosis with sometimes fatal consequences. These are prerequisite conditions for optimizing both the risk/benefit and cost/benefit ratios of DES. The development of full biodegradable DES stents and more effective and reproducible antiplatelet therapy is advancing to make these procedures even safer and more effective.
Related Articles
C-Reactive Protein and the Risk of Stent Thrombosis and Cardiovascular Events After Drug-Eluting Stent Implantation
Circulation, 11/04/09
Relevance Score: 68%
Intravascular Ultrasound Assessment of the Incidence and Predictors of Edge Dissections After Drug-Eluting Stent Implantation
JACC - Journal of the American College of Cardiology: Cardiovascular Interventions, 10/23/09
Relevance Score: 68%
Clinical Outcomes After Sirolimus-Eluting, Paclitaxel-Eluting, and Bare Metal Stents (from the First Phase of the Prospective Multicenter German DES.DE Registry)
The American Journal of Cardiology, 11/09/09
Relevance Score: 67%
Degradable and drug-eluting stents: Mixed results
Urology Times, 11/04/09
Relevance Score: 67%
Sirolimus-eluting stent placement for refractory renal artery in-stent restenosis: sustained patency and clinical benefit at 24 months
Vascular Medicine, 10/15/09
Relevance Score: 67%
Today in Cardiology...keeping you current
Receive free subspecialty "5-minute updates" via email
The Enhancing Secondary Prevention in Coronary Artery Disease trial
Canadian Medical Association Journal, 12/09/09
Effect of Atorvastatin on Platelet Thromboxane A2 Synthesis in Aspirin-Treated Patients With Acute Myocardial Infarction
The American Journal of Cardiology, 12/09/09
Meta-Analysis of Randomized Controlled Trials of Statins Versus Placebo in Patients With Heart Failure
The American Journal of Cardiology, 12/09/09
Sponsor
Article Search
Sponsor
Sponsor